315. MicroRNA-122 as a serum biomarker for hepatocellular carcinoma von McWhirter, D, Malik, H.Z, Fenwick, S.W, Poston, G.J, Kitteringham, N.R, Goldring, C.E, Lewis, P.J. Starkey, Park, B.K, Johnson, P.J, Palmer, D

Volltext

TWEAK/Fn14 signalling promotes cholangiocarcinoma niche formation and progression von Dwyer, Ben, Jarman, E.J, Gogoi-Tiwari, Jully, Ferreira-Gonzalez, S, Boulter, L, Guest, R.V, Kendall, T.J, Kurian, D, Kilpatrick, A.M, Robson, A.J, O'Duibhir, E, Man, T.Y, Campana, L, Starkey Lewis, P.J, Wigmore, S.J, Olynyk, John, Ramm, G.A, Tirnitz-Parker, Nina, Forbes, S.J

Volltext bestellen

Preclinical imaging methods for assessing the safety and efficacy of regenerative medicine therapies von Scarfe, L, Brillant, N, Kumar, J.D, Ali, N, Alrumayh, A, Amali, M, Barbellion, S, Jones, V, Niemeijer, M, Potdevin, S, Roussignol, G, Vaganov, A, Barbaric, I, Barrow, M, Burton, N.C, Connell, J, Dazzi, F, Edsbagge, J, French, N.S, Holder, J, Hutchinson, C, Jones, D.R, Kalber, T, Lovatt, C, Lythgoe, M.F, Patel, S, Patrick, P.S, Piner, J, Reinhardt, J, Ricci, E, Sidaway, J, Stacey, G.N, Starkey Lewis, P.J, Sullivan, G, Taylor, A, Wilm, B, Poptani, H, Murray, P, Goldring, C.E.P, Park, B.K

Volltext bestellen